Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1284
https://www.valueinhealthjournal.com/article/S1098-3015(16)32650-X/fulltext
Title :
Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32650-X&doi=10.1016/j.jval.2016.09.1284
First page :
A568
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1204